Episode Mentions
Bloomberg Intelligence · Jul 16, 2026
Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
“Stock surged 11% on strong Q2 earnings; CGM business growing 9.5%, nutrition recovering, Exact Sciences integration ongoing”
Psychedelic Drug Development and RegulationEli Lilly M&A Strategy and Contingent Value RightsPCSK9 Inhibitors and Cholesterol Management
View Analysis
Stock Movers · Jul 16, 2026
JB Hunt Gains, GH Research Rises, Abbott Laboratories Surges on 2026 Profit Guidance Raise
“Stock surged 14% on best day in 24 years after beating quarterly expectations and raising full-year profit guidance across medical devices and diabetes care.”
Abbott Laboratories earnings and guidance raiseMedical device industry strengthDiabetes care market performance
View Analysis
Mad Money w/ Jim Cramer · Apr 10, 2026
Mad Money w/ Jim Cramer 4/10/26
“Down 20% YTD after weak quarter and baby formula lawsuit; positioned for recovery despite 52-week lows”
Iran Ceasefire Geopolitical RiskDefense Contractor Stock ValuationsMissile and Munitions Supply Chain
View Analysis